Elevated Levels of Naturally-Occurring Autoantibodies Against the Extracellular Domain of p75NTR Aggravate the Pathology of Alzheimer's Disease.

Abstract

The extracellular domain (p75ECD) of p75 neurotrophin receptor (p75NTR) antagonizes Aβ neurotoxicity and promotes Aβ clearance in Alzheimer's disease (AD). The impaired shedding of p75ECD is a key pathological process in AD, but its regulatory mechanism is largely unknown. This study was designed to investigate the presence and alterations of naturally-occurring autoantibodies against p75ECD (p75ECD-NAbs) in AD patients and their effects on AD pathology. We found that the cerebrospinal fluid (CSF) level of p75ECD-NAbs was increased in AD, and negatively associated with the CSF levels of p75ECD. Transgenic AD mice actively immunized with p75ECD showed a lower level of p75ECD and more severe AD pathology in the brain, as well as worse cognitive functions than the control groups, which were immunized with Re-p75ECD (the reverse sequence of p75ECD) and phosphate-buffered saline, respectively. These findings demonstrate the impact of p75ECD-NAbs on p75NTR/p75ECD imbalance, providing a novel insight into the role of autoimmunity and p75NTR in AD.

• Authors: Chen-Yang He, Ding-Yuan Tian, Si-Han Chen, Wang-Sheng Jin, Yuan Cheng, Jia-Yan Xin, Wei-Wei Li, Gui-Hua Zeng, Cheng-Rong Tan, Jie-Ming Jian, Dong-Yu Fan, Jun-Rong Ren, Yu-Hui Liu, Yan-Jiang Wang, Fan Zeng
• Journal: Neuroscience bulletin (Neurosci Bull) Vol. 39 Issue 2 Pg. 261-272 (Feb 2023) ISSN: 1995-8218 [Electronic] Singapore
• PMID: 35974288 (Publication Type: Journal Article)
• Copyright: © 2022. Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences.

Chemical References

• Receptor, Nerve Growth Factor
• Amyloid beta-Peptides
• Autoantibodies

Topics

• Mice
• Animals
• Alzheimer Disease (pathology)
• Receptor, Nerve Growth Factor
• Amyloid beta-Peptides
• Autoantibodies
• Mice, Transgenic